# Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors

> **NCT01936961** · NA · WITHDRAWN · sponsor: **Western Regional Medical Center**

## Conditions studied

- Metastatic Non-Small Cell Lung Cancer
- Metastatic Colon Cancer
- Metastatic Triple Negative Breast Cancer

## Interventions

- **DRUG:** CTLA-4 Antibody
- **RADIATION:** Hypofractionated Radiotherapy

## Key facts

- **NCT ID:** NCT01936961
- **Lead sponsor:** Western Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01936961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01936961, "Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01936961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*